CO

CompuGroup Medical SE & Co KgaAXETRA CompuGroup Medical Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

0.793

Micro

Exchange

XETR - Xetra

COP.DE Stock Analysis

CO

Avoid

Based on Eyestock quantitative analysis, COP.DE`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

25/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

85.7 %

Greatly undervalued

Market cap $B

0.793

Dividend yield

3.50 %

Shares outstanding

52.235 B

CompuGroup Medical SE & Co. KGaA engages in the provision of e-Health solutions. The company is headquartered in Koblenz, Rheinland-Pfalz. The company went IPO on 2007-05-04. The firm focuses on providing software solutions to healthcare institutions. The activities are divided into six segments: Ambulatory Software Services (AIS), providing practice management software and medical records; Pharmacy Information Systems (PCS), including integrated clinical, administrative and financial software applications for pharmacies; Hospital Information Systems (HIS), such as laboratory and special care information systems; Communication & Data (C&D), offering software interfaces for pharmaceutical and medical equipment manufacturers; provides Picture Archiving and Communication Systems (PACS); Workflow & Decision Support (WDS), delivering software for management support aimed at healthcare payers, such as health insurers and managed care companies, and Internet Service Provider (ISP), providing Internet for healthcare providers.

View Section: Eyestock Rating